Go Back

Cybersecurity - US FDA Requirements – New Course ! Live Webinar


Location: California, USA
From: 2021/06/21 10:30
To: 2021/06/22 12:00
Posted by: WCS Compliance

About this event

Webinar Includes : All the training handouts , certificate ,Q/A and 90 mins Live Webinar

Overview

Cybersecurity is the art of protecting networks, devices, and data from unauthorized access or criminal use. It is the practice of ensuring confidentiality, integrity, and availability of information.

Cybersecurity is the preventing the theft / modification of e-records by unauthorized access. A growing concern for all – legal, financial, consumer, personal, and the FDA. t's a recent concern for the medical products industries, a result of their increased reliance on networked electronic software, records and signatures. Initially there were regulations such as 21 CFR Part 11 in the U.S. and Annex 11 in Europe. But they are insufficient to prevent this growing threat. The

FDA and news media have emphasized the prevalence of cybersecurity issues, such as data / identity theft, and hacking which pose hazards to many activities and businesses / industries. Cybersecurity is an issue that will only increase over time, as records become more electronic, and communications are more networked or accessible to outsiders / hackers. As a result the FDA has mandated further requirements to be taken by regulated industries to better control this threat, in validations, CGMP documentation, submissions to the Agency .

Why Should You Attend

Due to the growth of the cybersecurity threat to electronic records, computer-controlled manufacturing, and medical devices, the US FDA has issued Guidances for Industry, e.g.: 1) “Cybersecurity for Networked Medical Devices Containing Off-the-Shelf (OTS) Software Document”, and 2) “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices”, and 3) “Postmarket Management of Cybersecurity in Medical Devices” -- Draft. This webinar will focus on the key issues raised by the FDA, not just for devices, but expectations for industry. Cybersecurity in the medical products industries is coming under increased regulatory review. The Agency leaves the how of cybersecurity compliance up to the manufacturer, as long as the principles in the guidances are met in the resulting product and/or system; and on electronic-specific tools / techniques to achieve CGMP compliance . Updates, upgrades, new revisions / releases, service packs, and similar are automatically uploaded to a company’s systems, which can pose security risks, with the potential for introduction of compromised code, retrieval of confidential data, data integrity issues, and similar; and render previous computer systems’ verification and validations worthless. The necessary role of the system administrator adds another area of concern. This webinar will consider how cybersecurity is introduced into the CGMPs, design control (21 CFR 820.30) for devices, and post-production by the CAPA system, among others.

Webinar Takeaway
  • Cybersecurity and the FDA
  • Key Guidance Documents on Cybersecurity
  • FDA’s enforcement approaches
  • Network vunerablities issues
  • Cloud, updates and other concerns
  • FDA’s regulatory approach; Examples
  • Design, security tools and other requirements
  • NIST and related cybersecurity considerations
  • Validation and unique documentation requirements
Why will Benefit
  • Senior management in Devices, Combination Products
  • QA / RA
  • Software development, programming, documentation, testing teams
  • R&D
  • Engineering
  • Production
  • Operations
  • Marketing
  • Consultants; others tasked with product, process, electronic records software V&V responsibilities
FDA Faculty John E. Lincoln

John E. Lincoln

Medical Devices / Regulatory Consultant; also pharma and dietary supplements

Saint George, Utah

John E. Lincoln is Principal of J. E. Lincoln and Associates LLC, a consulting company, with over 32 years experience in U.S. FDA-regulated industries, 18 of which as a full time independent FDA-regulated industry consultant. Mr. Lincoln has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS / CGMP audits and problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He’s held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).



Save this event

Share with friends:

WCS Compliance

World Compliance Seminars Glorietta Circle

3472825400

Contact the Advertiser

worldcomplianceseminars.com/
Company Details
See other listings from this user


Featured Events


Career Options in Design
MIT ID Innovation is offering an interactive session on “Career ...
Ercess Inc.
TiEcon 2021
Register Now: https://bityl.co/6WFL Use promo code "FRAMEZ" to get 100% Discount ...